Last reviewed · How we verify

NCT03326466

Muscle Function, Central Nervous System Sensitization, and Pain Profiling in Patients With Subacromial Pain (SAP-CNSS).

Status unknown Last updated 21 February 2019
What this trial tests

trial in Subacromial Impingement Syndrome in 72 participants. Status unknown.

Timeline
13 November 2017
Primary endpoint
31 July 2020
31 July 2020

Quick facts

Lead sponsorHvidovre University Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment72
Start date13 November 2017
Primary completion31 July 2020
Estimated completion31 July 2020
Sites1 location across Denmark

Conditions studied

Sponsor

Hvidovre University Hospital

Who can join

Adults 18 to 65, any sex, with Subacromial Impingement Syndrome or Central Nervous System Sensitization. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this case-control study, the investigators compare shoulder muscle function, pain, and central nervous system sensitization in patients with Subacromial Pain (SAP) to that in healthy controls. The investigators also examine if a relationship exists between shoulder symptom duration and central sensitization, shoulder muscle function and shoulder pain distribution in patients with SAP.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Subacromial Impingement Syndrome

Currently open trials in the same condition.

Other Hvidovre University Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03326466.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing